Literature DB >> 3980729

Absence of branched chain acyl-transferase as a cause of maple syrup urine disease.

D J Danner, N Armstrong, S C Heffelfinger, E T Sewell, J H Priest, L J Elsas.   

Abstract

Decreased function of human mitochondrial branched chain alpha-ketoacid dehydrogenase complex results in branched chain ketoacidemia or maple syrup urine disease. Activity of this multienzyme complex varies from 0 to approximately 15% of wild type branched chain alpha-ketoacid dehydrogenase complex activity within the population of homozygous affected individuals. We used the technique of Western Blotting with antibodies against purified bovine liver branched chain alpha-ketoacid dehydrogenase complex to screen mitochondrial proteins from cultured human fibroblasts for immunocrossreactive proteins. This method probes the physical structure of the proteins forming this multienzyme complex. One patient with branched chain ketoacidemia lacked an immunoreactive transacylase protein. This protein catalyzes the transfer of the branched chain acyl group from the decarboxylase to reduced coenzyme A. Kinetic analysis of the enzyme activity in cell lysates from this patient confirmed that the complex would not utilize coenzyme A. Thus, we have defined a structural basis for an impaired multienzyme complex of mitochondria in man.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3980729      PMCID: PMC423615          DOI: 10.1172/JCI111783

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  17 in total

1.  Thiamine increases the specific activity of human liver branched chain alpha-ketoacid dehydrogenase.

Authors:  D J Danner; E D Davidson; L J Elsas
Journal:  Nature       Date:  1975-04-10       Impact factor: 49.962

2.  Subcellular distribution and cofactor function of human branched chain alpha-ketoacid dehydrogenase in normal and mutant cultured skin fibroblasts.

Authors:  D J Danner; L J Elsas
Journal:  Biochem Med       Date:  1975-05

3.  Maple syrup disease; isolation and identification of organic acids in the urine.

Authors:  J H MENKES
Journal:  Pediatrics       Date:  1959-02       Impact factor: 7.124

4.  How mitochondria import proteins from the cytoplasm.

Authors:  G Schatz
Journal:  FEBS Lett       Date:  1979-07-15       Impact factor: 4.124

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

Review 6.  The role of thiamin in maple syrup urine disease.

Authors:  L J Elsas; D J Danner
Journal:  Ann N Y Acad Sci       Date:  1982       Impact factor: 5.691

7.  In vivo and in vitro response of human branched chain alpha-ketoacid dehydrogenase to thiamine and thiamine pyrophosphate.

Authors:  D J Danner; F B Wheeler; S K Lemmon; L J Elsas
Journal:  Pediatr Res       Date:  1978-03       Impact factor: 3.756

8.  Stabilization of mammalian liver branched-chain alpha-ketoacid dehydrogenase by thiamin pyrophosphate.

Authors:  D J Danner; S K Lemmon; L J Elsas
Journal:  Arch Biochem Biophys       Date:  1980-06       Impact factor: 4.013

9.  Abnormal mRNA for argininosuccinate synthetase in citrullinaemia.

Authors:  T S Su; A L Beaudet; W E O'Brien
Journal:  Nature       Date:  1983-02-10       Impact factor: 49.962

10.  Pyruvate dehydrogenase complex activity in normal and deficient fibroblasts.

Authors:  K F Sheu; C W Hu; M F Utter
Journal:  J Clin Invest       Date:  1981-05       Impact factor: 14.808

View more
  18 in total

1.  Molecular diagnosis of maple syrup urine disease: screening and identification of gene mutations in the branched-chain alpha-ketoacid dehydrogenase multienzyme complex.

Authors:  Y Nobukuni; H Mitsubuchi; K Ohta; I Akaboshi; Y Indo; F Endo; I Matsuda
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

2.  Maple syrup urine disease: clinical and biochemical significance of gene analysis.

Authors:  Y Nobukuni; H Mitsubuchi; I Akaboshi; Y Indo; F Endo; I Matsuda
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

3.  Two different forms of maple syrup urine disease in a single family.

Authors:  U Langenbeck
Journal:  Hum Genet       Date:  1986-03       Impact factor: 4.132

4.  A structural abnormality of E1 component of the branched-chain alpha-keto acid dehydrogenase complex in maple syrup urine disease.

Authors:  Y Indo; A Kitano; I Akaboshi; F Endo; I Matsuda
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

Review 5.  Maple syrup urine disease 1954 to 1993.

Authors:  F Peinemann; D J Danner
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

6.  Evidence for both a regulatory mutation and a structural mutation in a family with maple syrup urine disease.

Authors:  B Zhang; H J Edenberg; D W Crabb; R A Harris
Journal:  J Clin Invest       Date:  1989-04       Impact factor: 14.808

7.  Gene analysis of Mennonite maple syrup urine disease kindred using primer-specified restriction map modification.

Authors:  H Mitsubuchi; I Matsuda; Y Nobukuni; R Heidenreich; Y Indo; F Endo; J Mallee; S Segal
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

8.  Maple syrup urine disease. Complete primary structure of the E1 beta subunit of human branched chain alpha-ketoacid dehydrogenase complex deduced from the nucleotide sequence and a gene analysis of patients with this disease.

Authors:  Y Nobukuni; H Mitsubuchi; F Endo; I Akaboshi; J Asaka; I Matsuda
Journal:  J Clin Invest       Date:  1990-07       Impact factor: 14.808

9.  Altered kinetic properties of the branched-chain alpha-keto acid dehydrogenase complex due to mutation of the beta-subunit of the branched-chain alpha-keto acid decarboxylase (E1) component in lymphoblastoid cells derived from patients with maple syrup urine disease.

Authors:  Y Indo; A Kitano; F Endo; I Akaboshi; I Matsuda
Journal:  J Clin Invest       Date:  1987-07       Impact factor: 14.808

10.  Mitochondrial import and processing of an in vitro synthesized human prebranched chain acyltransferase fragment.

Authors:  S Litwer; D J Danner
Journal:  Am J Hum Genet       Date:  1988-11       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.